The Research and Development team at Beacon Therapeutics is dedicated to advancing innovative gene therapies aimed at treating rare retinal diseases. This team, comprised of scientists and medical affairs experts, conducts cutting-edge research, develops experimental therapies, and performs rigorous clinical evaluations to ensure safety and efficacy. Their collaborative efforts are crucial to the company's mission of restoring and improving vision for individuals affected by these debilitating conditions.
View all